Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 6, 2008, Pages 719-723

  Rosenbaum, Cara ^a   Peace, David ^b   Rich, Elizabeth ^a   Van Besien, Koen ^a  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Granulocyte colony stimulating factor; Sickle cell disease; Stem cell mobilization

Indexed keywords

ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN C; HEMOGLOBIN S; IFOSFAMIDE; NARCOTIC AGENT;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE INCREASE; FEASIBILITY STUDY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HEMOGLOBINOPATHY; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKAPHERESIS; MONOTHERAPY; PAIN; PANCYTOPENIA; RECURRENT CANCER; SICKLE CELL ANEMIA; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTOSIS; MIDDLE AGED; PAIN; THROMBOPHILIA; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 43449119197     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.03.001     Document Type: Article

References (23)

1. Adler B.K., Salzman D.E., Carabasi M.H., Vaughan W.P., Reddy V.V., and Prchal J.T. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97 (2001) 3313-3314
2. Grigg A.P. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia. Blood 97 (2001) 3998-3999
3. Abboud M., Laver J., and Blau C.A. Granulocytosis causing sickle-cell crisis. Lancet 351 (1998) 959
4. Donato M.L., Champlin R.E., Van Besien K.W., et al. Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma. Leuk Lymphoma 35 (1999) 317-324
5. Körbling M., Przepiorka D., Huh Y.O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85 (1995) 1659-1665
6. Assis A., Conran N., Canalli A.A., Lorand-Metze I., Saad S.T., and Costa F.F. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin. Acta Haematol 113 (2005) 130-136
7. Kang E.M., Areman E.M., David-Ocampo V., et al. Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood 99 (2002) 850-855
8. Swerdlow P.S. Red cell exchange in sickle cell disease. Hematology Am Soc Hematol Educ Program (2006) 48-53
9. Fadlon E., Vordermeier S., Pearson T.C., et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 91 (1998) 266-274
10. Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology 5 (2001) 403-412
11. Kamble R.T., Tin-U C.K., and Carrum G. Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease. Bone Marrow Transplant 37 (2006) 1065-1066
12. Onitilo A.A., Lazarchick J., Brunson C.Y., Frei-Lahr D., and Stuart R.K. Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc 35 (2003) 3089-3092
13. Richard R.E., Siritanaratkul N., Jonlin E., Skarpidi E., Heimfeld S., and Blau C.A. Collection of blood stem cells from patients with sickle cell anemia. Blood Cells Mol Dis 35 (2005) 384-388
14. Larochelle A., Krouse A., Metzger M., et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 107 (2006) 3772-3778
15. Cashen A.F., Nervi B., and DiPersio J. AMD3100:CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol 3 (2007) 19-27
16. Gazitt Y., Freytes C.O., Akay C., et al. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients. Stem Cells Dev 16 (2007) 657-666
17. Calandra G., McCarty J., McGuirk J., et al. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 41 (2008) 331-338
18. Firth P.G. Anaesthesia for peculiar cells-a century of sickle cell disease. Br J Anaesth 95 (2005) 287-299
19. Van Besien K., Bartholomew A., Stock W., et al. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant 26 (2000) 445-449
20. Bhatia M., and Walters M.C. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41 (2008) 109-117
21. Vermylen C. Hematopoietic stem cell transplantation in sickle cell disease. Blood Rev 17 (2003) 163-166
22. Walters M.C., Patience M., Leisenring W., et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2 (1996) 100-104
23. Dew A., Collins-Jones D., Artz A., et al. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL unrelated donor searches for African-Americans with hematologic malignancies: paucity of HLA identical donors. Blood 110 Suppl 1 (2007) abstract 5064